Article metrics

Extended report
Efficacy and safety of the oral Janus kinase inhibitor peficitinib (ASP015K) monotherapy in patients with moderate to severe rheumatoid arthritis in Japan: a 12-week, randomised, double-blind, placebo-controlled phase IIb study

 

Online download statistics by month:

Online download statistics by month: December 2015 to September 2021

AbstractFullPdf
Dec 2015674164272
Jan 2016269160168
Feb 2016105115102
Mar 20161039183
Apr 20167579104
May 2016972202309
Jun 2016499140145
Jul 20162804867
Aug 20161915159
Sep 20161707646
Oct 20161447642
Nov 20161107742
Dec 2016935523
Jan 20171005833
Feb 2017285949
Mar 201707225
Apr 2017212159
May 2017110128
Jun 20172910225
Jul 201710510541
Aug 2017898817
Sep 201712212133
Oct 2017959326
Nov 201711911936
Dec 201712812822
Jan 201813413419
Feb 2018989637
Mar 2018969638
Apr 201819019121
May 201815515632
Jun 201820620741
Jul 2018919132
Aug 201817317240
Sep 201812712634
Oct 201814414439
Nov 201813713740
Dec 201812212222
Jan 201910910724
Feb 201912011654
Mar 20191089245
Apr 2019979438
May 2019877648
Jun 201910910941
Jul 2019989347
Aug 201910810137
Sep 2019666034
Oct 2019696525
Nov 2019766221
Dec 2019666021
Jan 2020838225
Feb 2020858021
Mar 202014614352
Apr 2020555157
May 2020605233
Jun 2020403820
Jul 2020474219
Aug 2020626138
Sep 2020706619
Oct 2020797523
Nov 2020767326
Dec 2020443619
Jan 2021564521
Feb 2021454022
Mar 202114714072
Apr 2021483723
May 202151489
Jun 2021362723
Jul 2021443720
Aug 2021342919
Sep 2021535028
Total865064603275